Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors

Những quyển sách tương tự

• Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel formulation for peritoneal dissemination
  Bằng: Emoto, Shigenobu, et al.
  Được phát hành: (2012)
• NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
  Bằng: Hamaguchi, T, et al.
  Được phát hành: (2005)
• An in vivo mechanism for the reduced peripheral neurotoxicity of NK105: a paclitaxel-incorporating polymeric micellar nanoparticle formulation
  Bằng: Nakamura, Iwao, et al.
  Được phát hành: (2017)
• A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation
  Bằng: Hamaguchi, T, et al.
  Được phát hành: (2007)
• NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel
  Bằng: Negishi, T, et al.
  Được phát hành: (2006)